Papamichael K, Vande Casteele N, Abraham BP, Ritter T, et al. Prior antibodies to infliximab or adalimumab are related to immunogenicity to vedolizumab in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol 2022 Nov 10. pii: S1542-3565(22)01053.
PMID: 36372372